Ligand Pharmaceuticals Incorporated (LGND) vs PTC Therapeutics, Inc. (PTCT)
- Ligand Pharmaceuticals Incorporated LGND 306.43 +2.48%
- PTC Therapeutics, Inc. PTCT 65.55 −0.18%
Ligand Pharmaceuticals Incorporated and PTC Therapeutics, Inc. are both Biotechnology companies. Ligand Pharmaceuticals Incorporated and PTC Therapeutics, Inc. are of similar size ($6.0B and $5.5B). PTC Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Ligand Pharmaceuticals Incorporated trades at 116×. Ligand Pharmaceuticals Incorporated grew revenue faster over the last twelve months: 1.03% against −35.1%. Ligand Pharmaceuticals Incorporated has the higher net margin (20.3% vs −9.17%) and the lower return on invested capital (1.27% vs 17.7%). Across the 18 metrics below, Ligand Pharmaceuticals Incorporated leads on 9 and PTC Therapeutics, Inc. on 9.
Valuation
Profitability
| Metric | LGND | PTCT | Biotechnology median |
|---|---|---|---|
| Gross margin | 95.22% | 93.20% | 65.16% |
| Operating margin | 9.29% | 12.78% | 0.00% |
| Net margin | 20.27% | (9.17%) | 0.00% |
| Free cash flow margin | 31.43% | (22.43%) | 0.00% |
| Return on equity | 5.38% | 61.08% | (50.12%) |
| Return on assets | 2.77% | (3.62%) | (45.60%) |
| Return on invested capital | 1.27% | 17.66% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack